| B-Cell Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 267show all (up to 200) |
|---|
| → investigated in trials for | Dexamethasonesmall molecule 781 trials (243 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 781 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 608 trials (211 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 608 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 568 trials (207 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 568 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 512 trials (167 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 512 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 456 trials (99 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 456 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 267 trials (69 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 267 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 223 trials (120 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 223 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 210 trials (27 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 210 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 203 trials (87 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 203 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 179 trials (71 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 179 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 174 trials (68 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 174 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 167 trials (71 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 167 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 166 trials (64 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 166 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 165 trials (58 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 165 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 144 trials (81 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 144 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 129 trials (43 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 129 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 128 trials (37 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 128 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 125 trials (77 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 125 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 92 trials (5 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 92 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 84 trials (15 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 84 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 80 trials (56 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 80 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 78 trials (22 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 76 trials (5 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 75 trials (23 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 75 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 70 trials (52 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 70 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 68 trials (20 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 68 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belantamab Mafodotinadc 62 trials (40 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elotuzumabmonoclonal antibody 58 trials (18 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Isatuximabmonoclonal antibody 58 trials (44 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 55 trials (26 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 54 trials (7 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 53 trials (15 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 50 trials (13 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teclistamabmonoclonal antibody 50 trials (46 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elranatamabmonoclonal antibody 46 trials (37 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 42 trials (38 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 40 trials (34 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 39 trials (25 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 37 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 36 trials (29 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 34 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 34 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 34 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 33 trials (13 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 33 trials (13 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 33 trials (30 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 33 trials (23 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talquetamabmonoclonal antibody 32 trials (27 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 32 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 28 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 28 trials (15 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 27 trials (7 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 26 trials (5 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 23 trials (10 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 22 trials (8 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 21 trials (10 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 21 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 20 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 19 trials (6 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 18 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 18 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall_molecule 18 trials (8 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 17 trials (8 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 16 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linvoseltamabmonoclonal antibody 16 trials (14 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 16 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 15 trials (10 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 14 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 14 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 14 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idecabtagene Vicleucelgene therapy 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 11 trials (5 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 11 trials (10 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nirogacestatsmall molecule 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ciltacabtagene Autoleucelgene therapy 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibritumomab Tiuxetanmonoclonal_antibody 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brexucabtagene Autoleucelgene therapy 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinaciclibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalan Flufenamidesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Procarbazinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Moxetumomab Pasudotoxadc 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Radiation Therapy 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bimiralisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic Cell Transplantation 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunomodulatory Oligonucleotide 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leuprolideother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Masitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Meloxicamsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirdametinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pasireotideother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pixantronesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | R-CHOP Regimen 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ridaforolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sotrastaurin Acetatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teniposidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |